N-tetralin-5-yl-4,5-dihydro-1H-imidazol-2-amine
ADVERTISEMENT
- Molecular formula
- C14H18N2
- CAS Number
- 56698-50-7
- IUPAC Name
- N-tetralin-5-yl-4,5-dihydro-1H-imidazol-2-amine
- Molecular Weight
- 235.31g/mol
- Melting Point
- (Celsius)
- Boiling Point
- (Celsius)
- Density
- 1.1450g/cm3
- Appearance
- can be described as colorless to pale yellow, depending on the degree of purity and specific synthesis methods utilized. As a solid, it is often available as small crystals or crystalline powder.
- Synonyms
- Tramazoline
Identification
Interesting facts
Exploring N-tetralin-5-yl-4,5-dihydro-1H-imidazol-2-amine
N-tetralin-5-yl-4,5-dihydro-1H-imidazol-2-amine is a fascinating compound that belongs to the class of imidazoles, which have garnered interest for their diverse biological activities. Here are some intriguing facts about this compound:
- Versatile Structure: The structure includes a tetralin moiety, which is known for its unique ring configuration, making it a useful scaffold in drug development.
- Pharmacological Potential: Compounds within the imidazole family are often recognized for their roles in medicinal chemistry. They can act as antifungal, antiviral, and anticancer agents.
- Synthesis Exploration: The synthesis of N-tetralin-5-yl-4,5-dihydro-1H-imidazol-2-amine typically involves multi-step reactions, showcasing the creativity required in synthetic organic chemistry.
- Research Applications: This compound is a target for researchers aiming to understand the intricate interactions of various nitrogenous bases, providing insights into metabolic pathways.
- Interdisciplinary Connections: The study of this compound connects fields such as pharmacology, medicinal chemistry, and organic synthesis, highlighting the interdisciplinary nature of modern scientific research.
As researchers continue to unravel the mysteries of imidazole derivatives, compounds like N-tetralin-5-yl-4,5-dihydro-1H-imidazol-2-amine stand at the forefront of innovative therapeutic exploration. Their unique structures and biological activities promise exciting opportunities for the design of new medicines.